Literature DB >> 6320933

Effect of sera from patients with Hodgkin's disease on normal donor lymphocytes containing parallel tubular structures.

J W Smit, N R Blom, M J van Luyn, G W van Imhoff, M R Halie.   

Abstract

Normal donor peripheral blood mononuclear cells incubated for 24 h with sera from patients with Hodgkin's disease were investigated by electron microscopy for the presence of parallel tubular structures (PTS) and/or amorphous electrondense granules (large granular lymphocytes = LGL). In comparison with normal human serum, 14 out of 29 sera of the patients induced a marked increase in the percentage of LGL. From a limited number of experiments it was likely that this increase is paralleled by an increase in Fcgamma receptor-bearing cells after the incubation. This serum effect did not show a correlation with the number of Fcgamma receptor-positive lymphocytes in the peripheral blood of the patients. A difference in the induction effect could be demonstrated between the sera from patients with a favourable and those with an unfavourable clinical course, but this distinction was not absolute. The presence or absence of splenic involvement by Hodgkin's disease does not apparently influence the effect of the sera. From experiments using sera positive for immune complexes or anti-Epstein-Barr virus antibodies, it seems unlikely that these factors are responsible for the observed increase in LGL.

Entities:  

Mesh:

Year:  1984        PMID: 6320933     DOI: 10.1007/bf00320037

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  23 in total

1.  Altered proportion of T mu-and T gamma-cell subpopulations in patients with Hodgkin's disease.

Authors:  S Romagnani; E Maggi; R Biagiotti; M G Giudizi; A Amadori; M Ricci
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

2.  Ultrastructure of cells binding immunoglobulin-coated erythrocytes in rheumatoid arthritis.

Authors:  F Reyes; A Le Go; F Delrieu; J F Bach
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

3.  Chronic T-cell leukemias. I. Morphology, cytochemistry and ultrastructure.

Authors:  C Costello; D Catovsky; M O'Brien; R Morilla; S Varadi
Journal:  Leuk Res       Date:  1980       Impact factor: 3.156

4.  Serum factors inhibiting some leukocytic functions in Hodgkin's disease.

Authors:  M Petrini; A Azzarà; R Polidori; M L Vatteroni; F Caracciolo; G Carulli; F Ambrogi
Journal:  Clin Immunol Immunopathol       Date:  1982-04

5.  Lymphoid subpopulations of peripheral blood and spleen in untreated Hodgkin's disease.

Authors:  M R Posner; E L Reinherz; J Breard; L M Nadler; D S Rosenthal; S F Schlossman
Journal:  Cancer       Date:  1981-09-01       Impact factor: 6.860

6.  Correlation between immune complexes and prognostic factors in Hodgkin's disease.

Authors:  P L Amlot; B Pussell; J M Slaney; B D Williams
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

7.  Subpopulations of human T lymphocytes. XVI. Maldistribution of T cell subsets associated with abnormal locomotion of T cells in untreated adult patients with Hodgkin's disease.

Authors:  S Gupta
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

8.  Parallel tubular arrays in severe combined immunodeficiency disease: an ultrastructural study of peripheral blood lymphocytes.

Authors:  C M Payne; J F Jones; O F Sieber; V A Fulginiti
Journal:  Blood       Date:  1977-07       Impact factor: 22.113

9.  Proliferation of T gamma cells with killer-cell activity in two patients with neutropenia and recurrent infections.

Authors:  A A Bom-van Noorloos; H G Pegels; R H van Oers; J Silberbusch; T M Feltkamp-Vroom; R Goudsmit; W P Zeijlemaker; A E von dem Borne; C J Melief
Journal:  N Engl J Med       Date:  1980-04-24       Impact factor: 91.245

10.  Spectrum of immunodeficiencies with Hodgkin's disease.

Authors:  J J Twomey; A H Laughter; L Rice; R Ford
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.